Skip to main content

Peer Review reports

From: Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes

Original Submission
15 Dec 2023 Submitted Original manuscript
16 Dec 2023 Author responded Author comments - Guobao Wu
8 Jan 2024 Reviewed Reviewer Report
16 Jan 2024 Reviewed Reviewer Report
1 Feb 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 2
16 Dec 2023 Submitted Manuscript version 2
10 Feb 2024 Reviewed Reviewer Report
19 Apr 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 3
19 Apr 2024 Submitted Manuscript version 3
24 Apr 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 4
24 Apr 2024 Submitted Manuscript version 4
24 Apr 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 5
24 Apr 2024 Submitted Manuscript version 5
28 Apr 2024 Reviewed Reviewer Report
29 Apr 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 6
29 Apr 2024 Submitted Manuscript version 6
1 May 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 7
1 May 2024 Submitted Manuscript version 7
8 May 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 8
8 May 2024 Submitted Manuscript version 8
26 May 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 9
26 May 2024 Submitted Manuscript version 9
22 Jun 2024 Author responded Author comments - Guobao Wu
Resubmission - Version 10
22 Jun 2024 Submitted Manuscript version 10
Publishing
28 Jun 2024 Editorially accepted
30 Jul 2024 Article published 10.1186/s12891-024-07640-6

You can find further information about peer review here.

Back to article page